Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Seagen Inc. (SGEN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
08/17/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
08/17/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
08/17/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
08/17/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
08/16/2023 144 Form 144 - Report of proposed sale of securities:
08/16/2023 144 Form 144 - Report of proposed sale of securities:
08/16/2023 144 Form 144 - Report of proposed sale of securities:
08/16/2023 144 Form 144 - Report of proposed sale of securities:
08/16/2023 144 Form 144 - Report of proposed sale of securities:
08/16/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Seagen Phase 3 Trial of TUKYSA ® in Combination with Antibody-Drug Conjugate ado-trastuzumab emtansine Meets Primary Endpoint of Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer"
08/09/2023 4 LIU JEAN I (Chief Legal Officer) has filed a Form 4 on Seagen Inc.
Txns: Gifted 11,124 shares @ $0
08/02/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
07/14/2023 8-K Quarterly results
07/05/2023 4 ROMP CHARLES R (EVP, Commercial U.S.) has filed a Form 4 on Seagen Inc.
Txns: Sold 708 shares @ $192.46, valued at $136.3k
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 4 HIMES VAUGHN B (Chief Technical Officer) has filed a Form 4 on Seagen Inc.
Txns: Sold 16,215 shares @ $195.2865, valued at $3.2M
Exercised 16,215 options to buy @ $41.04, valued at $665.5k
06/09/2023 SC 13G/A Capital International Investors reports a 3.9% stake in Seagen Inc.
06/07/2023 144 Form 144 - Report of proposed sale of securities:
06/02/2023 4 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on Seagen Inc.
Txns: Granted 2,044 shares @ $0
Granted 2,044 shares @ $0
06/02/2023 4 GRYSKA DAVID W (Director) has filed a Form 4 on Seagen Inc.
Txns: Granted 2,044 shares @ $0
06/02/2023 4 LOVE TED W (Director) has filed a Form 4 on Seagen Inc.
Txns: Granted 2,044 shares @ $0
06/02/2023 4 Orwin John A (Director) has filed a Form 4 on Seagen Inc.
Txns: Granted 2,044 shares @ $0
06/02/2023 4 Seth Alpna (Director) has filed a Form 4 on Seagen Inc.
Txns: Granted 2,044 shares @ $0
06/02/2023 4 Simonian Nancy A (Director) has filed a Form 4 on Seagen Inc.
Txns: Granted 2,044 shares @ $0
06/02/2023 4 SWAIN SANDRA M (Director) has filed a Form 4 on Seagen Inc.
Txns: Granted 2,044 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy